ABIVAX Société Anonyme
ABVX
$102.42
-$1.87-1.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 2.48M | 4.98M |
| Total Other Revenue | 6.55M | 11.40M | 11.65M | 10.77M | 9.83M |
| Total Revenue | 6.55M | 11.40M | 11.65M | 10.77M | 9.83M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.55M | 11.40M | 11.65M | 10.77M | 9.83M |
| SG&A Expenses | 37.63M | 40.45M | 42.07M | 44.94M | 47.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.84M | -1.81M | -1.80M | -948.80K | -75.70K |
| Total Operating Expenses | 209.66M | 199.77M | 198.84M | 196.90M | 193.88M |
| Operating Income | -203.11M | -188.37M | -187.19M | -186.13M | -184.05M |
| Income Before Tax | -212.48M | -199.27M | -190.69M | -191.83M | -191.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -212.48 | -199.27 | -190.69 | -191.83 | -191.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -212.48M | -199.27M | -190.69M | -191.83M | -191.96M |
| EBIT | -203.11M | -188.37M | -187.19M | -186.13M | -184.05M |
| EBITDA | -202.00M | -187.16M | -186.00M | -185.09M | -183.18M |
| EPS Basic | -3.36 | -3.15 | -3.02 | -3.25 | -3.47 |
| Normalized Basic EPS | -2.09 | -1.96 | -1.91 | -2.07 | -2.23 |
| EPS Diluted | -3.36 | -3.15 | -3.02 | -3.25 | -3.47 |
| Normalized Diluted EPS | -2.09 | -1.96 | -1.91 | -2.07 | -2.23 |
| Average Basic Shares Outstanding | 253.17M | 252.65M | 252.19M | 239.24M | 226.29M |
| Average Diluted Shares Outstanding | 253.17M | 252.65M | 252.19M | 239.24M | 226.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |